Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-09-18

Clinical Trial Update: Keloid Scarring: Treatment and Pathophysiology [Phase 4]

View source ↗

Summary

Phase 4 clinical trial on keloid scarring has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Queen Mary University of London | Conditions: Keloid Scar | Phase 4 | Status: WITHDRAWN